Use of sentinel lymph node biopsy in elderly patients with breast cancer – 10-year experience from a Swiss university hospital

BACKGROUND: The Choosing Wisely initiative recommended the omission of routine sentinel lymph node biopsy (SLNB) in patients ≥ 70 years of age, with clinically node-negative, early stage, hormone receptor (HR) positive and human epidermal growth factor receptor 2 (Her2) negative breast cancer in Aug...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidinger, Martin, Maggi, Nadia, Dutilh, Gilles, Mueller, Madleina, Eller, Ruth S., Loesch, Julie M., Schwab, Fabienne D., Kurzeder, Christian, Weber, Walter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249276/
https://www.ncbi.nlm.nih.gov/pubmed/37287038
http://dx.doi.org/10.1186/s12957-023-03062-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249276/
https://www.ncbi.nlm.nih.gov/pubmed/37287038
http://dx.doi.org/10.1186/s12957-023-03062-1

Ejemplares similares